Clinical trials

  • ETRANACOGENE DEZAPARVOVEC for Hemophilia B
  • CAMIZESTRANT for Estrogen receptor-positive HER2-negative advanced breast cancer
  • DOMVANALIMAB for Muscle-invasive bladder cancer | Bladder cancer
  • SEMAGLUTIDE for Obesity|Heart failure with reduced ejection fraction
  • SACITUZUMAB TIRUMOTECAN for Triple-negative breast cancer
  • KarXT for Psychosis associated with Alzheimer's disease|Alzheimer's disease dementia
  • FLUDARABINE PHOSPHATE for Hematological malignancy | Allogeneic haematopoietic stem cell transplantation (reduced-intensity conditioning)
  • OPEVESOSTAT TOSILATE for Metastatic castration-resistant prostate cancer
  • VOLRUSTOMIG for Locally advanced cervical cancer
  • MORPHINE SULFATE for Fibrotic interstitial lung disease|Interstitial lung disease
  • trastuzumab deruxtecan for HER2-positive advanced or metastatic non-small cell lung cancer
  • ALNUCTAMAB for Relapsed and/or Refractory Multiple Myeloma